Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 31 entries
View as:

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT01702090 Org: User:
Start: 02/29/12 End: 06/30/12 Due: 06/30/13

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Phase: N/A Priority: Normal
NCT ID: NCT02385058 Org: User:
Start: 10/31/05 End: 01/31/06 Due: 01/31/07

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT02559583 Org: User:
Start: 07/31/14 End: 06/30/16 Due: 06/30/17

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01726335 Org: User:
Start: 01/31/06 End: 03/31/08 Due: 03/31/09

A Registry Study of Participants With Multiple Myeloma in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT03955900 Org: User:
Start: 05/29/19 End: 06/30/22 Due: 06/30/23

An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00766506 Org: User:
Start: 05/31/08 End: 09/30/08 Due: 09/30/09

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

Phase: N/A Priority: Normal
NCT ID: NCT04829669 Org: User:
Start: 04/30/24 End: 08/30/24 Due: 08/30/25

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

Phase: N/A Priority: Normal
NCT ID: NCT03107793 Org: User:
Start: 04/19/17 End: 07/20/21 Due: 07/20/22

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03782376 Org: User:
Start: 12/20/18 End: 01/10/23 Due: 01/10/24

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT06408935 Org: User:
Start: 04/17/24 End: 07/15/29 Due: 07/15/30

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05347095 Org: User:
Start: 09/27/22 End: 05/17/27 Due: 05/17/28

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT06285318 Org: User:
Start: 12/18/23 End: 10/23/26 Due: 10/23/27

A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

Phase: N/A Priority: Normal
NCT ID: NCT05901649 Org: User:
Start: 07/05/23 End: 06/05/26 Due: 06/05/27

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03998683 Org: User:
Start: 09/03/19 End: 11/30/21 Due: 11/30/22

A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics

Phase: N/A Priority: Normal
NCT ID: NCT02712463 Org: User:
Start: 07/31/15 End: 04/30/16 Due: 04/30/17

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03425591 Org: User:
Start: 05/11/16 End: 08/11/22 Due: 08/11/23

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Phase: N/A Priority: Normal
NCT ID: NCT00254930 Org: User:
Start: 09/30/03 End: 06/30/06 Due: 06/30/07

A Real-world Study in Participants With Smoldering Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06472778 Org: User:
Start: 03/29/15 End: 10/30/25 Due: 10/30/26

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04829318 Org: User:
Start: 04/26/21 End: 07/22/24 Due: 07/22/25

A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02713282 Org: User:
Start: 04/28/16 End: 03/26/18 Due: 03/26/19

Treatment-Resistant Depression Cohort in Europe

Phase: N/A Priority: Normal
NCT ID: NCT03373253 Org: User:
Start: 02/13/18 End: 01/24/20 Due: 01/24/21

A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

Phase: N/A Priority: Normal
NCT ID: NCT04232228 Org: User:
Start: 02/07/20 End: 04/04/22 Due: 04/04/23

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05125679 Org: User:
Start: 11/23/21 End: 07/28/23 Due: 07/28/24

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02874560 Org: User:
Start: 08/12/14 End: 07/12/17 Due: 07/12/18

A Study of Prophylaxis for Migraine Patients With Topiramate in India

Phase: N/A Priority: Normal
NCT ID: NCT01836874 Org: User:
Start: 05/31/07 End: 07/31/08 Due: 07/31/09